ha.mwangi
Submits third-party assay reports on material purchased directly. Based in Tampere.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.95%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042524 | Semax | Homopeptide | HOMO-2605-S5227 | Janoshik | 2026-Q3 | 99.93 | 5.75 | 100.9 | Supplier-supplied | 0 | PASS |
| AX-2026-042055 | Tirzepatide | HYB | HYB-2512-W7237 | Janoshik | 2026-Q2 | 99.06 | 5.91 | 95.7 | Buyer-sourced | 0 | PASS |
| AX-2026-042047 | Retatrutide | HYB | HYB-2509-W6465 | Janoshik | 2026-Q1 | 98.85 | 3.58 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019469 | BPC-157 | JEEP | JEEP-2506-R8215 | Janoshik | 2025-Q3 | 98.93 | 3.43 | 102.5 | Buyer-sourced | 0 | PASS |
| AX-2025-018992 | Tirzepatide | ASY | ASY-{CAT}-1938 | Kestrel | 2025-Q3 | 98.97 | 4.80 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020762 | Tirzepatide | SGN | SGN-2503-P9641 | Nordanalyt | 2025-Q2 | 97.86 | 4.14 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004937 | NAD+ | GGPeps | GGPE-2405-A3279 | Janoshik | 2024-Q4 | 98.04 | 8.11 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005048 | Retatrutide | SSA | SSA-2405-G6509 | Janoshik | 2024-Q3 | 97.33 | 6.92 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004983 | Semaglutide | MKM | MKM-2403-C4617 | Kestrel | 2024-Q2 | 99.78 | 6.03 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004276 | PT-141 (Bremelanotide) | QSC | QSC-2402-X6189 | Janoshik | 2024-Q1 | 99.55 | 3.50 | 92.9 | Buyer-sourced | 0 | PASS |